Cardinal Health, Inc. (CAH)

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
United States Revenue	249.12B	220.99B	225.23B
United States Revenue Growth	12.73%	-1.88%	10.71%
International Revenue	1.71B	1.67B	1.68B
International Revenue Growth	2.52%	-0.71%	3.96%
Revenue (Other)	-92.00M	-84.00M	-85.00M
Revenue (Total)	250.74B	222.58B	226.83B
Revenue (Total) Growth	12.65%	-1.87%	10.66%

Revenue Breakdown

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Pharmaceutical and Specialty Solutions Revenue	231.36B	204.64B	210.02B
Pharmaceutical and Specialty Solutions Revenue Growth	13.05%	-2.56%	11.23%
Global Medical Products and Distribution Revenue	12.79B	12.64B	12.38B
Global Medical Products and Distribution Revenue Growth	1.22%	2.06%	1.30%
Other Segment Revenue	6.68B	5.38B	4.51B
Other Segment Revenue Growth	24.12%	19.28%	12.21%
Revenue (Other)	-92.00M	-84.00M	-85.00M
Revenue (Total)	250.74B	222.58B	226.83B
Revenue (Total) Growth	12.65%	-1.87%	10.66%

EBIT

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Pharmaceutical and Specialty Solutions Segment Profit	2.67B	2.26B	2.02B
Pharmaceutical and Specialty Solutions Segment Profit Growth	18.38%	12.06%	7.12%
Global Medical Products and Distribution Segment Profit	178.00M	135.00M	92.00M
Global Medical Products and Distribution Segment Profit Growth	31.85%	46.74%	-
Other Segment Profit	684.00M	516.00M	423.00M
Other Segment Profit Growth	32.56%	21.99%	6.82%
Corporate Profit	-1.22B	-634.00M	-1.29B
Operating Income (Total)	2.31B	2.28B	1.24B
Operating Income (Total) Growth	1.63%	83.03%	65.29%

EBIT 2

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Corporate Profit	-1.22B	-634.00M	-1.29B
Operating Income (Total)	2.31B	2.28B	1.24B
Operating Income (Total) Growth	1.63%	83.03%	65.29%

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error